Treatment of depression in diabetes: impact on mood and medical outcome (Q34959974)

5 August 2017

1 reference

title

Treatment of depression in diabetes: impact on mood and medical outcome (English)

1 reference

5 August 2017

1

Patrick J Lustman

1 reference

5 August 2017

Ray E Clouse

2

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Journal of Psychosomatic Research

5 August 2017

published in

1 reference

5 August 2017

volume

53

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

917-924

1 reference

5 August 2017

cites work

Depression and Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depression and the reporting of diabetes symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Coping, control, and adjustment in Type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depression and poor glycemic control: a meta-analytic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Association of depression and diabetes complications: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Hospitalization and mortality of diabetes in older adults. A 3-year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

A review of the relationship between depression and diabetes in adults: is there a link?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depression in adults with diabetes. Results of 5-yr follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depressive symptoms and occurrence of type 2 diabetes among Japanese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Correlation of esophageal motility abnormalities with neuropsychiatric status in diabetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Biomedical and psychiatric risk factors for retinopathy among children with IDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depression in patients with cardiac disease: a practical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Going to the heart of the matter: do negative emotions cause coronary heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Even minimal symptoms of depression increase mortality risk after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

The influence of anxiety and depression on outcomes of patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Exaggerated platelet reactivity in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depression, heart rate variability, and acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Enhancing central and peripheral insulin activity as a strategy for the treatment of endogenous depression--an adjuvant role for chromium picolinate?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Insulin tolerance test in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Glucose Metabolism in Unipolar Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Relative insulin insensitivity and cortisol secretion in depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depression and risk for onset of type II diabetes. A prospective population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depressed mood is a factor in glycemic control in type 1 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Stress and diabetic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

WITHDRAWN: Antidepressants for depression in medical illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depression in diabetics: A critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

The functional significance of biochemical alterations in streptozotocin-induced diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Twenty-four-hour cortisol profiles demonstrate exaggerated nocturnal rise in diabetic children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Effects of insulin and streptozotocin-induced diabetes on brain norepinephrine metabolism in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Effects of insulin and streptozotocin-induced diabetes on brain tryptophan and serotonin metabolism in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

The course of major depression in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Sertraline in diabetic neuropathy: response and biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Cognitive behavior therapy for depression in type 2 diabetes mellitus. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Predicting response to cognitive behavior therapy of depression in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Adherence to diabetes regimens: empirical status and clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Persistence of depressive symptoms in diabetic adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Coronary artery disease in IDDM. Gender differences in risk factors but not risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Does psychological distress predict the risk of ischemic stroke and transient ischemic attack? The Caerphilly Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Prospective study of depressive symptoms and risk of stroke among japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depressive symptoms and increased risk of stroke mortality over a 29-year period.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Tests of glycemia in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Clinical and psychosocial factors associated with achievement of treatment goals in adolescents with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Diabetic control and progression of retinopathy in elderly patients: five-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Relationship of Self-efficacy and Binging to Adherence to Diabetes Regimen Among Adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

The effect of prescribed daily dose frequency on patient medication compliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

7 January 2021

Medication compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Drug compliance in pediatrics. Clinical and research issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Cognitive function and information processing in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Treatment preferences among depressed primary care patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Patients' perspectives on the management of emotional distress in primary care settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Public attitude towards psychiatric treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Long-term functioning and well-being outcomes associated with physical activity and exercise in patients with chronic conditions in the Medical Outcomes Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Loss of hypoglycemia awareness in an adolescent with type 1 diabetes mellitus during treatment with fluoxetine hydrochloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Relationship of psychiatric illness to impotence in men with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Depression masquerading as diabetic neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Acute effect of different antidepressants on glycemia in diabetic and non-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Effects of Alprazolam on Glucose Regulation in Diabetes: Results of double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Selective serotonin reuptake inhibitors and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

7 January 2021

The influence of physical activity on mental well-being.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

7 January 2021

Self-management of diabetes mellitus: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

7 January 2021

Major depression and medication adherence in elderly patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3999%2802%2900416-6

7 January 2021

10.1016/S0022-3999(02)00416-6

Identifiers

DOI

1 reference

5 August 2017

1 reference